Agenebio, Inc.
Records under this name other than the patents Agenebio, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 4 of 4 · Back to Agenebio, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,312,721 | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment Lapsed on the fee record Ended Apr 26, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2026 | From the USPTO record |
| US 11,160,785 | Methods and compositions for improving cognitive function Lapsed on the fee record Ended Nov 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 2, 2025 | From the USPTO record |
| US 9,801,879 | Pyridazine derivatives, compositions and methods for treating cognitive impairment Lapsed on the fee record Ended Oct 31, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 31, 2025 | From the USPTO record |
| US 9,145,372 | Pyridazine derivatives, compositions and methods for treating cognitive impairment Lapsed on the fee record Ended Sep 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 29, 2023 | From the USPTO record |